Home » ATS MEDICAL TO ACQUIRE 3F THERAPEUTICS
ATS MEDICAL TO ACQUIRE 3F THERAPEUTICS
ATS Medical, Inc. developer, manufacturer and marketer of state-of-the-art cardiac
surgery products and services, today announced a definitive agreement under
which ATS will acquire all the outstanding shares of privately-held 3F Therapeutics
in a stock for stock transaction. Based in Irvine, California, 3F Therapeutics
is an early stage medical device company at the forefront of the emerging field
of minimally invasive beating heart tissue valve replacement. The acquisition
of 3F Therapeutics is viewed as a major step in executing ATS Medical's longstanding
vision of obtaining a leadership position in all segments of the cardiac surgery
market.
PR Newswire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
14May
-
23May
-
30May
-
20Jun
-
21Oct